The axillary sentinel lymph nodes of breast cancer
Conditions
Interventions
Experimental group:Transareolar subcutaneous injection of Sonazoid
Control group:Transareolar subcutaneous injection of SonoVue
Sponsors
The Seventh Affiliated Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
Female
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Patients who meet the trial conditions must comply with all of the following requirements when randomly grouped: 1.Adult female (aged 18 or above); 2. The breast mass is classified as BI-RADS 4a or above.
Exclusion criteria
Exclusion criteria: 1.Subjects who have been diagnosed with breast cancer and have received radiotherapy, chemotherapy or endocrine suppression therapy; 2. There is an abscess on the skin near the nipples; 3. Severe ulceration of the skin in the nipple and areola areas, with no normal skin available for drug injection; 4. Pregnant women (with negative blood HCG test results) and lactating women; 5. Those who suffer from personality or mental disorders and have no or limited capacity for civil conduct.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of axillary sentinel lymph nodes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse reactions to contrast agents;Accuracy of percutaneous contrast-enhanced ultrasound in diagnosing axillary sentinel lymph nodes; | — |
Countries
China
Contacts
Public ContactFengping Liang
The Seventh Affiliated Hospital, Sun Yat-sen University
Outcome results
None listed